28 results
HIV HAART Medications - Classification by Names and Mechanism - Updated 01/2021
 - NRTIs
 - NNRTIs
HIV HAART Medications ... - Classification ... @serotavirus #HIV ... Antiretroviral #Therapy #Pharmacology ... #Classification
** See updated 01/2021 version here- https://www.grepmed.com/images/6497 **

HIV HAART Medications - Grouped by Brand Names and
images/6497 ** HIV ... compendium of HIV ... @serotavirus #HIV ... Antiretroviral #Therapy #Pharmacology ... #Classification
Antiretroviral Medication Names and 3-Letter Abbreviations by Class

Paul E. Sax, MD

#Antiretroviral #Medication #Names #Classification #HAART #Classes
Antiretroviral Medication ... Antiretroviral #Medication ... #Names #Classification ... HAART #Classes #HIV ... #AIDS #Pharmacology
HIV Antiretroviral Medications Cheat Sheet

NRTIs
Integrase Inhibitors
NNRTIs
PIs
Fusion Inhibitors
CCR5 Antagonist
Post Attachment Inhibitor
Combination Pills
NRTI-Sparing
Resistance Mutations Summary - https://hivdb.stanford.edu/ 

By
HIV Antiretroviral ... Medications Cheat ... @kbrownmd #HIV ... Names #NNRTIs #Classification ... #Pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
known to have HIV ... diagnosed with HIV ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
HIV/AIDS Medications - Targets of Action

Fusion inhibitors
Inhibitors of reverse transcriptase
Inhibitors of HIV protease

#HIVAIDS #pharmacology #targets #action
HIV/AIDS Medications ... Inhibitors of HIV ... protease #HIVAIDS ... #pharmacology #
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Infections in HIV-AIDS ... to 5 mg/kg/day IV ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Leishmaniasis in HIV-AIDS ... amphotericin B 2–4 mg/kg IV ... Leishmaniasis #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Infections in HIV-AIDS ... PO (or 400 mg IV ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Candidiasis in HIV-AIDS ... for effective treatment ... IDSA #Prevention #Treatment ... opportunistic #infections #HIVAIDS ... #pharmacology